Law firm investigates GeneDX for possible securities violations after stock drops 45% on weak revenue guidance

Block & Leviton is investigating GeneDX Holdings Corp. for potential securities law violations following a sharp 45% drop in its stock price after the company reported first quarter revenue below expectations and lowered its 2026 revenue guidance. The firm is reaching out to investors who suffered losses to explore recovery options and may file legal action on their behalf. Investors who purchased GeneDX stock and experienced losses, regardless of whether they sold, are encouraged to contact Block & Leviton. The law firm also invites whistleblowers with non-public information to assist in the investigation and potentially receive SEC rewards.